« Back
Home /
D21-2393

D21-2393

Item no.	TMO-T19873-50mg
Manufacturer	TargetMol
CASRN	834919-19-6
Amount	50mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	Chen X, Liu D, Wu Y, Song H, Liu Y, Jiang J, Hu P. A single-dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban at 30-90?mg in healthy Chinese volunteers. Xenobiotica. 2017 Jul;47(7):592-599. doi: 10.1080/00498254.2016.1207825. Epub 2016 Aug 25. PubMed PMID: 27560456.
Smiles	C(N[C@H]1[C@@H](NC(C(NC2=CC=C(Cl)C=N2)=O)=O)CC[C@H](C(O)=O)C1)(=O)C3=NC4=C(S3)CN(C)CC4
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	834919-19-6, D21 2393 , Edoxaban 4-Carboxylic Acid , D21-2393 , UNII-IV344R972X
Available
Short Description	D21-2393 subjects received a single-oral-dose of edoxaban 30-90 mg in each study occasion under fasting condition. Serial blood samples were collected to measure the plasma concentrations of edoxaban and its major active metabolite D21-2393. Meanwhile, PT, INR, aPTT were measured pre- and post-dose.
Shipping	cool pack
Storage	-20°
Target names or alias	D21 2393 , Edoxaban 4-Carboxylic Acid , D21-2393 , UNII-IV344R972X
Molecular Weight	520, 99

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T19873-50mg-datasheet.pdf

TMO-T19873-50mg-safety-datasheet.pdf